Company profilePharmaceutical#313 of 1,318 in Pakistan1 DRAP alert

BAYER SCHERING PHARMA.

Pharmaceutical company · 55 brands · 80 molecules

Ranked #1 of 24 companies in Hormone Regulators

55 registered products 47 pharmaceutical brands 80 distinct molecules 1 DRAP alert

Company overview

registered products

pharmaceutical brands

distinct molecules

therapeutic classes

DRAP alerts

BAYER SCHERING PHARMA. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 55 product registrations across 80 distinct molecules. Its portfolio is concentrated in Hormone Regulators and Oestrogens. DRAP has issued 1 alert involving its products.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by BAYER

3 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Hormone Regulators 1

MirenaiusRs 12,161.5

Other 2

Advantan Fatty0.1% 10GRs 383.8 Advantanfatty10gRs 404

Top molecules by brand count

Estradiol5 brands

Thiamine5 brands

Diflucortolone5 brands

Cyanocobalamin4 brands

Nicotinamide4 brands

Biotin4 brands

Pyridoxine4 brands

Riboflavin4 brands

Tocopherol4 brands

Cyproterone3 brands

Therapeutic classes

Conditions treated

Price band (DRAP official ceilings)

Registered products priced by source

DRAP-official8 products · Rs 380.13 – Rs 7,736.68

DVAGO12 products · Rs 212.88 – Rs 5,124.13

Servaid21 products · Rs 66.09 – Rs 12,161.5

Median across source: Rs 978.17

Regulatory record

1 alert in the DRAP feed we track.

Recall Alert: RECALL OF XARELTO 15MG TABLET, BATCH NO. BXK4E11, DUE TO A LABELING ERROR ON

2025-05-23

Competitive set

Companies whose registered portfolio overlaps most with this one.

Bayer Pakistan Private Limited28 shared molecules

ZAFA PHARMACEUTICAL LABORATORIES (PVT) LTD.26 shared molecules

MASS PHARMA (PRIVATE) LIMITED24 shared molecules

NovaMed Pharmaceuticals(Pvt.)Ltd21 shared molecules

Pfizer Laboratories (Pvt) Ltd.21 shared molecules

ENGLISH PHARMACEUTICALS INDUSTRIES20 shared molecules

HIMONT PHARMACEUTICALS (PVT) LTD.20 shared molecules

MARTIN DOW PHARMACEUTICALS (PAK) LTD.19 shared molecules

AGP (PRIVATE) LTD.17 shared molecules

BLOOM PHARMACEUTICALS (PVT) LTD.17 shared molecules

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

Bayer Pakistan Private Limited holds 46 molecules not in this portfolio

ZAFA PHARMACEUTICAL LABORATORIES (PVT) LTD. holds 155 molecules not in this portfolio

MASS PHARMA (PRIVATE) LIMITED holds 130 molecules not in this portfolio

Get the full profile for BAYER

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included